Live Update
From the Liveblog of
Wednesday, June 17, 2020
Germany’s CureVac starts human trials for COVID-19 vaccine
German biotech firm CureVac has won permission to start human trials of a promising coronavirus vaccine, regulators announce, as the global race to stop the pandemic gathers pace.
The Paul Ehrlich Institute (PEI), the German body responsible for assessing clinical trials and approving vaccines, calls the approval “an important milestone.”
In a statement, it said it had given CureVac the green light based on “a careful assessment of the risk/benefit profile of the vaccine candidate.”
Globally, there are now 11 coronavirus vaccines being tested on humans, according to the World Health Organization.
— AFP
If you’d like to comment, join
The Times of Israel Community.
The Times of Israel Community.
JOIN THE TOI COMMUNITY
Already a member? Log in here







